Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical and translational science"
DOI: 10.1111/cts.13151
Abstract: Hyperphosphatemia is present in most patients with end-stage renal disease (ESRD) and has been associated with increased cardiovascular mortality. Phosphate binders (calcium-based and calcium free) are the mainstay pharmacologic treatment to lower phosphorus levels in…
read more here.
Keywords:
calcification inflammation;
vascular calcification;
treatment;
inflammation endothelial ... See more keywords